685 related articles for article (PubMed ID: 4537488)
1. International collaborative studies on potency assays of diphtheria and tetanus toxoids.
Van Ramshorst JD; Sundaresan TK; Outschoorn AS
Bull World Health Organ; 1972; 46(2):263-76. PubMed ID: 4537488
[TBL] [Abstract][Full Text] [Related]
2. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
Gupta RK; Siber GR
Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
[TBL] [Abstract][Full Text] [Related]
3. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
Winsnes R; Sesardic D; Daas A; Behr-Gross ME
Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262
[TBL] [Abstract][Full Text] [Related]
4. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of tetanus and diphtheria antitoxins in mouse sera by indirect haemagglutination.
Maheshwari SC; Sharma SB; Kumar A; Sokhey J
J Commun Dis; 1998 Mar; 30(1):23-8. PubMed ID: 9842161
[TBL] [Abstract][Full Text] [Related]
6. Collaborative assay of a proposed international standard for tetanus toxoid (adsorbed).
van Ramshorst JD; Sundaresan TK
Bull World Health Organ; 1972; 46(1):53-66. PubMed ID: 4537335
[TBL] [Abstract][Full Text] [Related]
7. An antibody induction method in mice for the potency assays of diphtheria and tetanus components in combined vaccines.
Maheshwari SC; Sharma SB; Kumar A; Sokhey J
J Commun Dis; 1998 Sep; 30(3):139-46. PubMed ID: 10093418
[TBL] [Abstract][Full Text] [Related]
8. Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, lot 2), for potency determination of diphtheria-tetanus- acellular pertussis combined vaccine.
Iwaki M; Komiya T; Fukuda T; Arakawa Y; Takahashi M
Jpn J Infect Dis; 2003 Aug; 56(4):183-5. PubMed ID: 14583650
[No Abstract] [Full Text] [Related]
9. Comparison of in vivo and in vitro methods for determining unitage of diphtheria antitoxin in adsorbed diphtheria-tetanus (DT) and diphtheria-tetanus-pertussis (DTP) vaccines.
Shinde YP; Jadhav SS
Dev Biol Stand; 1996; 86():245-60. PubMed ID: 8785954
[TBL] [Abstract][Full Text] [Related]
10. [The determination of the protective potency of the diphtheria component in combined vaccines by the indirect hemagglutination (IHA) method].
Unver SD; Ozcengiz E
Mikrobiyol Bul; 1990 Oct; 24(4):327-35. PubMed ID: 2287290
[TBL] [Abstract][Full Text] [Related]
11. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines - extended study: correlation of serology with in vivo toxin neutralisation.
Sesardic D; Winsnes R; Rigsby P; Behr-Gross ME
Pharmeuropa Bio; 2004 Jan; 2003(2):69-76. PubMed ID: 14960263
[TBL] [Abstract][Full Text] [Related]
12. Potency control of tetanus and diphtheria toxoids, adsorbed, produced in Bulgaria.
Vrancheva S; Vulchev V; Bachev S
Prog Immunobiol Stand; 1970; 4():548-52. PubMed ID: 5482199
[No Abstract] [Full Text] [Related]
13. Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay.
Aggerbeck H; Heron I
Dev Biol Stand; 1996; 86():297-301. PubMed ID: 8785958
[TBL] [Abstract][Full Text] [Related]
14. Collaborative study for the establishment of tetanus vaccine (adsorbed) Third International Standard and European Pharmacopoeia Biological Reference Preparation batch no. 2.
Sesardic D; Winsnes R; Rigsby P; Gaines-Das R
Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):45-72. PubMed ID: 11705100
[TBL] [Abstract][Full Text] [Related]
15. Calibration of European pharmacopoeia biological reference preparation for diphtheria vaccine (adsorbed) batch 4.
Stickings P; Rigsby P; Buchheit KH; Sesardic D
Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):1-9. PubMed ID: 20144448
[TBL] [Abstract][Full Text] [Related]
16. Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines.
Knight PA; Roberts PA
Dev Biol Stand; 1986; 65():245-53. PubMed ID: 3493931
[TBL] [Abstract][Full Text] [Related]
17. Immunization against neonatal tetanus in New Guinea. 5. Laboratory assayed potency of tetanus toxoids and relationship to human antitoxin response.
Pittman M; Kolb RW; Barile MF; Hardegree MC; Seligmann EB; Maclennan R; Schofield FD
Bull World Health Organ; 1970; 43(3):469-78. PubMed ID: 5313001
[TBL] [Abstract][Full Text] [Related]
18. Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use.
Winsnes R; Hendriksen C; Sesardic D; Akkermans A; Daas A
Dev Biol Stand; 1999; 101():277-88. PubMed ID: 10566802
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR
Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
[TBL] [Abstract][Full Text] [Related]
20. Experimental study on estimating the immunogenic potency of diphtheria and/or tetanus toxoids in monovaccines and associated vaccines.
Durbacă S; Andronescu C; Diaconescu A
Roum Arch Microbiol Immunol; 1996; 55(2):119-31. PubMed ID: 9253238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
